Rejuvenation Technologies Inc.
YC S18 · Active · mRNA therapeutics to extend healthspan entering clinical trials
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
 SFA TherapeuticsShared: immune system, clinical trial, anti-agingActiveAI | AI | Active | YCS21 |
 Panoptic BioShared: clinical trialNot statedOther | Other | Not stated | Antler2026 |
 Sixfold BioscienceShared: nanomedicine, gene therapy, mrnaActiveOther | Other | Active | YCW18 |
 Amptiv BiosciencesShared: mrna therapeuticNot statedOther | Other | Not stated | Antler2024 |
 ParcelBioShared: gene therapy, mrna, extendActiveOther | Other | Active | YCW24 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
 PowerShared: clinical trialNot statedOther | Other | Not stated | SPC2021 |
 Kenosha AIShared: clinical trialNot statedAI | AI | Not stated | Antler2024 |
 Sensible BiotechnologiesShared: mrna therapeuticActiveOther | Other | Active | YCS21 |
 Kopra BioShared: immune system, gene therapy, fdaActiveOther | Other | Active | YCS24 |
 MiracleShared: clinical trial, clinical stage, systemActiveOther | Other | Active | YCW23 |
Also from S18
All of S18| Company | Category | Status |
|---|---|---|
 64x BioEnabling next generation medicines. A comprehensive platform and…ActiveAI | AI | Active |
 ActiveloopDatabase for AIActiveAI, Devtools | AI, Devtools | Active |
 AestheticYour AI-powered creative apprentice 🪄ActiveAI, Devtools | AI, Devtools | Active |
 Alpha VantageDeveloper-friendly and enterprise-grade APIs for financial market…ActiveAI, Data, Devtools | AI, Data, Devtools | Active |
 Anima AppAnima - Design Agent | AgentGrid.io - Shared drive for humans & agentsActiveAI, Devtools | AI, Devtools | Active |
 AnnieCannonsConnecting Survivors to Careers in TechActiveAI | AI | Active |
About Rejuvenation Technologies Inc.
Stanford-patented essential drug platform unlocks the healthspan, which is limited by short telomeres. Extends mouse lifespan by equivalent of 10 years in humans. Reverses 5-10 years of telomere shortening with one dose in one day. Preclinical efficacy in 4 organ systems including immune system. Entering clinical stage. CEO is Subject #1 in longevity trial. 50+ granted patents, 7 patent families. FDA INTERACT cleared. Raising $10M seed extension ($2M+ wired) to fund 3 investigator-initiated trials. Readouts in Q3 2027. $6.8B in comparable mRNA-LNP M&A in last 12 months.
- YC batch
- S18 · Summer 2018
- Status, per YC
- Active
- Category
- Other
- Team size
- 2
- Location
- San Francisco, CA, USA
- Checked
- 1h ago
YC tags: Anti-Aging, Gene Therapy, Nanomedicine
Rejuvenation Technologies Inc.: questions
Which YC batch was Rejuvenation Technologies Inc. in?
Rejuvenation Technologies Inc. was in Y Combinator's Summer 2018 batch (S18).
Is Rejuvenation Technologies Inc. still active?
Y Combinator lists Rejuvenation Technologies Inc. as active.
Where is Rejuvenation Technologies Inc. based?
Rejuvenation Technologies Inc. lists San Francisco, CA, USA as its location on YC's directory.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.